209 related articles for article (PubMed ID: 18209866)
1. [Exogenous Cushing's syndrome and glucocorticoid withdrawal].
Romanholi DJ; Salgado LR
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1280-92. PubMed ID: 18209866
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
[TBL] [Abstract][Full Text] [Related]
3. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
Hopkins RL; Leinung MC
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid induced adrenal insufficiency.
Prete A; Bancos I
BMJ; 2021 Jul; 374():n1380. PubMed ID: 34253540
[TBL] [Abstract][Full Text] [Related]
5. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
Güven A; Gülümser O; Ozgen T
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
[TBL] [Abstract][Full Text] [Related]
6. Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.
Paragliola RM; Papi G; Pontecorvi A; Corsello SM
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053578
[TBL] [Abstract][Full Text] [Related]
7. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
Vollenweider P; Waeber G
Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
[TBL] [Abstract][Full Text] [Related]
8. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.
Balasko A; Zibar Tomsic K; Kastelan D; Dusek T
J Neuroendocrinol; 2022 Aug; 34(8):e13172. PubMed ID: 35726348
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced changes in adrenal cortex function].
Krysiak R; Kowalcze K; Okopień B
Wiad Lek; 2017; 70(3 pt 2):633-643. PubMed ID: 28713097
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome: Two sides of the same coin.
Nachawi N; Li D; Lansang MC
Cleve Clin J Med; 2024 Apr; 91(4):245-255. PubMed ID: 38561211
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate use of potent topical glucocorticoids in infants.
Ozon A; Cetinkaya S; Alikasifoglu A; Gonc EN; Sen Y; Kandemir N
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):219-25. PubMed ID: 17396439
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
Coureau B; Bussières JF; Tremblay S
Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic doses of glucocorticoids: implications for oral medicine.
Baid SK; Nieman LK
Oral Dis; 2006 Sep; 12(5):436-42. PubMed ID: 16910913
[TBL] [Abstract][Full Text] [Related]
15. Steroid withdrawal syndrome after successful treatment of Cushing's syndrome: a reminder.
Bhattacharyya A; Kaushal K; Tymms DJ; Davis JR
Eur J Endocrinol; 2005 Aug; 153(2):207-10. PubMed ID: 16061825
[TBL] [Abstract][Full Text] [Related]
16. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.
Dinsen S; Baslund B; Klose M; Rasmussen AK; Friis-Hansen L; Hilsted L; Feldt-Rasmussen U
Eur J Intern Med; 2013 Dec; 24(8):714-20. PubMed ID: 23806261
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
18. HPA failure and glucocorticoid therapy.
Christy NP
Hosp Pract (Off Ed); 1984 Jul; 19(7):77-9, 83-4, 87-9, concl. PubMed ID: 6330137
[No Abstract] [Full Text] [Related]
19. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate.
Malik KJ; Wakelin K; Dean S; Cove DH; Wood PJ
Ann Clin Biochem; 1996 May; 33 ( Pt 3)():187-9. PubMed ID: 8791979
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
Tsan KW; Kuo CY
Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):936-43. PubMed ID: 3001216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
